Ubrogepant is Effective for the Acute Treatment of Migraine in Patients with an Insufficient Response to Triptans

被引：0
|
作者：
Blumenfeld, Andrew M. [1 ]
Goadsby, Peter J. [2 ]
Dodick, David W. [3 ]
Hutchinson, Susan [4 ]
Liu, Chengcheng [5 ]
Finnegan, Michelle [5 ]
Trugman, Joel M. [5 ]
Szegedi, Armin [5 ]
机构：
[1] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA USA
[2] Kings Coll London, NIHR Wellcome Trust Kings Clin Res Facil, London, England
[3] Mayo Clin, Phoenix, AZ USA
[4] Orange Cty Migraine & Headache Ctr, Irvine, CA USA
[5] Allergan Plc, Madison, NJ USA
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-OR-015
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [31] Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual Migraine
    Pavlovic, J. M.
    Ailani, J.
    Hutchinson, S.
    Lai, H.
    Dabruzzo, B.
    Yu, S. Y.
    Trugman, J. M.
    MacGregor, A.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 153 - 154
  • [32] Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual Migraine
    Pavlovic, J. M.
    Ailani, J.
    Hutchinson, S.
    Lai, H.
    Dabruzzo, B.
    Yu, S. Y.
    Trugman, J. M.
    MacGregor, A.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 103 - 103
  • [33] Ubrogepant Was Safe and Well Tolerated in the Acute Treatment of Perimenstrual Migraine
    Pavlovic, Jelena M.
    Ailani, Jessica
    Hutchinson, Susan
    Lai, Hongxin
    Dabruzzo, Brett
    Yu, Sung Yun
    Trugman, Joel M.
    MacGregor, E. Anne
    NEUROLOGY, 2021, 96 (15)
  • [34] Unmet Needs in Japanese Patients Who Report Insufficient Efficacy with Triptans for Acute Treatment of Migraine: Retrospective Analysis of Real-World Data
    Hirata, Koichi
    Ueda, Kaname
    Komori, Mika
    Ye, Wenyu
    Kim, Yongin
    Cotton, Sarah
    Jackson, James
    Treuer, Tamas
    PAIN AND THERAPY, 2021, 10 (01) : 415 - 432
  • [35] Unmet Needs in Japanese Patients Who Report Insufficient Efficacy with Triptans for Acute Treatment of Migraine: Retrospective Analysis of Real-World Data
    Koichi Hirata
    Kaname Ueda
    Mika Komori
    Wenyu Ye
    Yongin Kim
    Sarah Cotton
    James Jackson
    Tamas Treuer
    Pain and Therapy, 2021, 10 : 415 - 432
  • [36] Negative predictors of clinical response to triptans in patients with migraine
    Ishii, M.
    Sakairi, Y.
    Hara, H.
    Imagawa, A.
    Shimizu, S.
    Takahashi, J.
    Nagamine, A.
    Naito, Y.
    Masuda, Y.
    Usami, S.
    Kiuchi, Y.
    NEUROLOGICAL SCIENCES, 2012, 33 (02) : 453 - 461
  • [37] Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis
    Laohapiboolrattana, Wattakorn
    Jansem, Priabprat
    Anukoolwittaya, Prakit
    Roongpiboonsopit, Duangnapa
    Hiransuthikul, Akarin
    Pongpitakmetha, Thanakit
    Thanprasertsuk, Sekh
    Rattanawong, Wanakorn
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [38] Negative predictors of clinical response to triptans in patients with migraine
    M. Ishii
    Y. Sakairi
    H. Hara
    A. Imagawa
    S. Shimizu
    J. Takahashi
    A. Nagamine
    Y. Naito
    Y. Masuda
    S. Usami
    Y. Kiuchi
    Neurological Sciences, 2012, 33 : 453 - 461
  • [39] MIDAS scores and response to Triptans in migraine patients on Topiramate
    Hering-Hanit, R
    CEPHALALGIA, 2003, 23 (07) : 714 - 714
  • [40] Ubrogepant to Treat Acute Migraine in Adults
    Edinoff, Amber N.
    Casey, C. Austin
    Colon, Marc A.
    Zaheri, Alexa R.
    Gregoire, Courtney M.
    Bourg, Margaret M.
    Kaye, Alan D.
    Kaye, Jessica S.
    Kaye, Adam M.
    Kaye, Rachel J.
    Tirumala, Sridhar R.
    Viswanath, Omar
    Urits, Ivan
    NEUROLOGY INTERNATIONAL, 2021, 13 (01): : 32 - 45
12345